AngioDynamics to Participate in the UBS Global Healthcare Conference

Audio By Carbonatix

LATHAM, N.Y.--(BUSINESS WIRE)--Oct 27, 2025--

AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced, that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the UBS Global Healthcare Conference at 8:00 a.m. ET on Monday, Nov. 10 2025.

A live webcast of the fireside chat will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.

About AngioDynamics, Inc.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251027943936/en/

CONTACT: Investors:

AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: HEALTH ONCOLOGY CARDIOLOGY MEDICAL DEVICES

SOURCE: AngioDynamics, Inc.

Copyright Business Wire 2025.

PUB: 10/27/2025 04:30 PM/DISC: 10/27/2025 04:30 PM

http://www.businesswire.com/news/home/20251027943936/en